Navigation Links
Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium
Date:8/6/2009

WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, today released its updated Pharmacor Rheumatoid Arthritis report which now includes patient share and sales forecasts through 2018 for Rigel Pharmaceuticals' investigational novel oral agent, fostamatinib disodium (R788). The report update is based on Rigel Pharmaceuticals' recent announcement regarding additional Phase II clinical data for fostamatinib disodium.

The report finds that, owing to its impressive efficacy, the spleen tyrosine kinase (Syk) inhibitor fostamatinib disodium will likely precede TNF-alpha inhibitors such as Amgen/Wyeth/Takeda's Enbrel and Abbott/Eisai's Humira in the treatment cascade for rheumatoid arthritis. Phase II data shows that fostamatinib disodium's efficacy is comparable to that of currently-available biologic agents in patients with inadequate response to treatment with methotrexate. According to the report, if the agent is priced lower than currently-available biologics, physicians may be willing to prescribe fostamatinib disodium as an alternative to premium-priced biologics.

However, Decision Resources conservatively forecasts that fostamatinib disodium's patient share will reach up to 1.8 percent and it will garner major-market sales of $330 million in 2018.

"Fostamatinib disodium's patient share and sales will be considerably lower than our evaluation of the other novel oral agent in development for rheumatoid arthritis--Pfizer's Jak-3 inhibitor CP-690550," said Decision Resources Analyst Joanna Kim, M.Ed. "Fostamatinib disodium's impact is likely to be less than that of CP-690550 because of uncertainties about its efficacy in the TNF-refractory population and the absence of a head-to-head trial against a TNF-alpha inhibitor."

About Decision Resources


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BCBSGA Announces Decision to Cover H1N1 Vaccine Administration
2. PET can help guide treatment decisions for a common pediatric cancer
3. WellPoint Announces Decision to Cover H1N1 Vaccine Administration
4. United States Patent Office Issues Decision in Re-examination Proceedings
5. Providence Service Corporation Comments on U.S. Court of Appeals Decision to Uphold Federal Injunction Blocking Californias 10% Cut in Medi-Cal Payments
6. Stem Cell Decision Opens New Doors, May Spur More Research
7. TriServ Likely to Protest Decision
8. Communicating science to decision makers
9. Brain section multitasks, handling phonetics and decision-making
10. The decision about the incision: Is midline or transverse better for abdominal surgery?
11. Jeff Stewart Joins Decision Resources, Inc. as Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... The results of a 40+ year study in ... to cause mesothelioma, regardless of the volume of exposure. ... Surviving Mesothelioma website. , The study conducted by ... found that, among the 138 cases of mesothelioma that ... of them happened at plants that had, at some ...
(Date:5/30/2015)... 2015 EHO offers a suite of ... gives hospices the ability to manage their drug-spend for ... business model, EHO has been able to compete with ... clients and survive among the giants of the industry. ... three years ago, it has simplified the way hospices ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
(Date:5/30/2015)... 30, 2015 This year the ... Pulmonary Horizons to offer one of the most diverse ... discuss successful practices to diagnose, treat and manage patients ... Pulmonary Horizons Conference is Interaction with Multidisciplinary Healthcare ... Overall Needs of Patients with COPD," said Brian W. ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
Breaking Medicine News(10 mins):Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2
... a medical conference that takes place entirely online, announces participation of ... Prevention Center. Dr. Kaskel to present "Improved Patient Outcomes and ... ... MA (PRWEB) February 18, 2009 -- CardioCareLive , the first ...
... 18 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... company that controls,and operates pharmaceutical companies in ... that contractually controlled Beijing Liang Fang,Pharmaceutical Co., ... rights,transfer contract with Beijing Yipuan Bio-Medical Technology ...
... Has Resisted Well, - Continued Reduction in Net Debt, In millions of euros ... 168.4 ... 19.3 26.8, EBITDA margin ... Current operating income* 4.6 12.0, ...
... to educate, inform, and empower the people of Chicago, ... its 25-minute live call-in show, "Community Health," on Chicago ... 6:00 PM on Channel 21. Monday,s program, with ... the Balancing Center in Chicago will discuss the health ...
... Michael J. Fox Foundation for Parkinson,s Research awarded ... to develop neuroimaging technologies that would allow scientists ... protein in the living human brain. Such technologies ... and treatment of PD. Investigators could more accurately ...
... and survival is poorer, new report finds , , WEDNESDAY, ... rates continue to decline, an American Cancer Society report ... more advanced stages of cancer than whites, the report,s ... each stage of diagnosis of most types of cancers. ...
Cached Medicine News:Health News:Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy 2Health News:Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy 3Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 2Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 3Health News:Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug 4Health News:PCAS: 2008 Results 2Health News:PCAS: 2008 Results 3Health News:Save Your Money and Your Health 2Health News:Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain 2Health News:Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain 3Health News:Cancer Death Rates Decline Among Blacks, But Disparities Linger 2Health News:Cancer Death Rates Decline Among Blacks, But Disparities Linger 3
(Date:5/29/2015)... May 29, 2015  Today, UL LLC, a ... global provider of electronic quality management systems (EQMS) ... which will leverage the strengths of both organizations ... system implementation and comprehensive advice and guidance for ... EQMS capabilities to UL,s strength in regulatory services ...
(Date:5/29/2015)... May 28, 2015 Research and Markets ( ... "North America MRI Market - Growth, Trends And Forecasts ... The North American MRI systems market is estimated ... to $1.58 billion by 2020 with a CAGR of ... three types namely, the open system, closed system and ...
(Date:5/29/2015)... 29, 2015 Actinobac Biomed, NovoPedics, Inc. and ... investments from Foundation Venture Capital Group (FVCG), have been ... as part of the Start-Up Stadium and Company Presentation ... James M. Golubieski . The annual convention, ... be held in Philadelphia in ...
Breaking Medicine Technology:UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3
... DATATRAK International, Inc. (OTCQX: DATA), a technology and ... trials industry, premiered the release of its safety system Monday ... Case Manager ™ collects individual case safety report (ICSR) data ... for transmission to regulatory authorities. The Safety Case Manager is ...
... June 15 Adeona Pharmaceuticals, Inc. (Amex: ... testing subsidiary, HartLab, has expanded its in-house diagnostic testing ...  Adeona believes that that this expansion of services will ... and beyond and is consistent with Adeona,s plans to ...
Cached Medicine Technology:DATATRAK Premieres Safety System at DIA 2DATATRAK Premieres Safety System at DIA 3Adeona Announces HartLab Expansion Into Microbiology Testing Services 2Adeona Announces HartLab Expansion Into Microbiology Testing Services 3Adeona Announces HartLab Expansion Into Microbiology Testing Services 4Adeona Announces HartLab Expansion Into Microbiology Testing Services 5
Hydraulic ophthalmic stretcher for eye surgery....
... a staining solution for cataract surgery. ... performing a safe phaco-emulsification procedure. Inadequate ... may result in an incomplete capsulorhexis, ... radial capsule tears and associated complications. ...
Rhex-ID (Trypan Blue 0.8 mg)....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Medicine Products: